Columbia Asia Hospital Bukit Jalil has officially launched its new Cardiac Catheterisation Laboratory (Cath Lab), marking a significant step forward in expanding access to advanced heart and vascular care.
The launch was officiated by Columbia Asia Hospital Bukit Jalil Chief Executive Officer Dr Sharonpal Singh together with Consultant Cardiologist Dr Prem Nathan Arumuganathan along with Medical Consultants and Heads of Departments, underscoring the hospital's continued investment in specialist capabilities since opening in 2023.
Heart disease remains one of Malaysia's most serious health concerns. According to the Department of Statistics Malaysia's Causes of Death 2024 report, released in 2025, ischaemic heart disease continues to be the leading cause of death nationwide, underscoring the importance of early detection and faster access to treatment.
The new Cath Lab allows doctors to diagnose and treat heart and blood vessel conditions through minimally invasive procedures performed via small access points rather than open surgery. This approach helps many patients avoid major operations and typically results in less discomfort, shorter hospital stays and quicker recovery.
The facility also enables faster intervention during emergencies such as heart attacks, when every minute matters. In addition to cardiology procedures, the lab supports selected interventional radiology treatments, expanding modern, image-guided options for patients who may benefit from less invasive care.
